Next Article in Journal
Effects of Gelatin Hydrogel Containing Anti-Transforming Growth Factor-β Antibody in a Canine Filtration Surgery Model
Next Article in Special Issue
Zebrafish as a Model for the Study of Microvascular Complications of Diabetes and Their Mechanisms
Previous Article in Journal
Melatonin and Vitamin D Interfere with the Adipogenic Fate of Adipose-Derived Stem Cells
Previous Article in Special Issue
The Glyoxalase System and Methylglyoxal-Derived Carbonyl Stress in Sepsis: Glycotoxic Aspects of Sepsis Pathophysiology
Review

Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention

1
Department of Medicine I and Clinical Chemistry, University Hospital Heidelberg, 69120 Heidelberg, Germany
2
Department of Nuclear Medicine, University Hospital Heidelberg, 69120 Heidelberg, Germany
3
German Center for Diabetes Research (DZD), 85764 Munich-Neuherberg, Germany
4
Joint Heidelberg-IDC Translational Diabetes Program, Helmholtz Center, 85764 Munich-Neuherberg, Germany
5
Institute of Pharmacology, University of Heidelberg, 69120 Heidelberg, Germany
6
Molecular Medicine Partnership Unit, University of Heidelberg, 69120 Heidelberg, Germany
7
Institute for Diabetes and Cancer (IDC), Helmholtz Center, 85764 Munich-Neuherberg, Germany
*
Author to whom correspondence should be addressed.
Academic Editor: Casper G. Schalkwijk
Int. J. Mol. Sci. 2017, 18(5), 984; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18050984
Received: 25 January 2017 / Revised: 11 April 2017 / Accepted: 2 May 2017 / Published: 5 May 2017
(This article belongs to the Special Issue Glyoxalase System in Health and Disease 2017)
Advanced glycation end-products (AGEs) are non-enzymatic protein and amino acid adducts as well as DNA adducts which form from dicarbonyls and glucose. AGE formation is enhanced in diabetes and is associated with the development of diabetic complications. In the current review, we discuss mechanisms that lead to enhanced AGE levels in the context of diabetes and diabetic complications. The methylglyoxal-detoxifying glyoxalase system as well as alternative pathways of AGE detoxification are summarized. Therapeutic approaches to interfere with different pathways of AGE formation are presented. View Full-Text
Keywords: advanced glycation end-products; diabetes; glyoxalase; aldose reductase; methylglyoxal; glyoxal; 3-deoxyglucosone advanced glycation end-products; diabetes; glyoxalase; aldose reductase; methylglyoxal; glyoxal; 3-deoxyglucosone
Show Figures

Figure 1

MDPI and ACS Style

Brings, S.; Fleming, T.; Freichel, M.; Muckenthaler, M.U.; Herzig, S.; Nawroth, P.P. Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention. Int. J. Mol. Sci. 2017, 18, 984. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18050984

AMA Style

Brings S, Fleming T, Freichel M, Muckenthaler MU, Herzig S, Nawroth PP. Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention. International Journal of Molecular Sciences. 2017; 18(5):984. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18050984

Chicago/Turabian Style

Brings, Sebastian, Thomas Fleming, Marc Freichel, Martina U. Muckenthaler, Stephan Herzig, and Peter P. Nawroth 2017. "Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention" International Journal of Molecular Sciences 18, no. 5: 984. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18050984

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop